Product information

From Health Canada

New search

The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.

Current status:

Marketed

Current status date:

2011-01-18

Original market date: See footnote 1

2011-01-18

Product name:

4% CITANEST FORTE DENTAL WITH EPINEPHRINE 1:200,000

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section .

DIN:

02347695

Product Monograph/Veterinary Labelling:

Date: 2010-03-26 Product monograph/Veterinary Labelling (PDF version ~ 175K)

Company: 

DENTSPLY CANADA LIMITED
1  525 Rowntree Dairy Road
Woodbridge
Ontario
Canada  L4L 7K6

Class: 

Human

Dosage form(s):

Solution

Route(s) of administration:

Block/Infiltration

Number of active ingredient(s):

2

Schedule(s):

Ethical  

Biosimilar Biologic Drug:

No

American Hospital Formulary Service (AHFS): See footnote 3

72:00.00   LOCAL ANESTHETICS

Anatomical Therapeutic Chemical (ATC): See footnote 4

N01BB54  PRILOCAINE, COMBINATIONS

Active ingredient group (AIG) number:See footnote 5

0211806001

List of active ingredient(s)
Active ingredient(s) Strength
EPINEPHRINE 0.005 MG / ML
PRILOCAINE HYDROCHLORIDE 40 MG / ML

Application information

Related information

Contact us

Version 3.8.0
Date modified: